The Office of Research and Tulane IT Department asks that researchers complete an important survey about current and potential future research activities.  Survey instructions and the Survey may be found HERE. Thank you!

CRISPR-Based Methods and Novel compositions for Treating Vascular Disorders

Background

Tulane University is actively seeking commercial entities to further develop and commercialize CRISPR-based compositions and methods of use to impair or promote angiogenesis.

Applications

Controlling angiogenesis in patients has implication in many disease states including tumor growth, age-related macular degeneration, and cancer metastasis.

Current Work

These compositions have been explored with in vitro assays including EC-fibroblast co-culture.

Inventors

Bo Yu, PhD

Available For

Exclusive License in a Field
Non-exclusive License
Scientific Collaboration

For more information, please contact: